The Board of Directors of Asian Phytoceuticals Public Company Limited (the "Company") at the meeting No. 1/2022 on February 28, 2022 approved the resolution to establish subsidiaries and a center as follows: Company name KILLER T CELL FOR PETS CO., LTD. Objective. To use the innovative immunotherapy based on Killer T Cells to treat pets infected with fungi, bacteria, AIDS and other viruses that have not been successfully treated with any drugs and to distribute this innovative immunotherapy both in Thailand and overseas.

Registered capital THB 10 million. Equity stake: APCO 55%. Company name KILLER T CELL CO., LTD. Objective To operate the business of using the innovative immunotherapy based on Killer T Cells in Thailand and overseas to treat infection with all types of viruses, fungi, and bacteria, and cancer symptoms at all stages.

Center name Killer T Cell Therapy for HIV. Objective To provide service in Thailand to infected individuals from around the world and/or use remote monitoring along the lines of telemedicine for those who are unable to travel to receive service in Thailand, with the signing of an MOU with Eco Green Concept, the company that will bring in infected individuals numbering 200 per month to receive treatment commencing in Quarter 2 of 2022.